Frastim (filgrastim biosimilar) / RPG Life Sci - LARVOL DELTA

SAFETY OF HEMATOPOIETIC STEM CELL DONATION. RETROSPECTIVE ANALYSIS OF EARLY POST DONATION FOLLOW UP IN VOLUNTARY DONORS REGISTERED IN DKMS FOUNDATION DONOR CENTER, POLAND (EHA 2019) - "To mobilize the HPC lenogfrastim or filgrastim was used in standard dosage (7-10 µg/kg/day for 4 or 5 consequent days). Abnormalities in the 1FU are mild and mainly refer to CBC, especially in women regardless of the age group. Severe side effects are extremely rare. "

Retrospective data